Skip to main content

Pharmacy

By Susan Morse | 11:27 am | May 17, 2023
If approved, Bertagnolli would oversee a $47B annual budget that funds biomedical research linked to half of the drugs approved by the FDA.
By Susan Morse | 11:32 am | May 16, 2023
Its model combined precision patient recruitment from a diverse population and the delivery of hundreds of home clinical trials, the company says.
By Jeff Lagasse | 03:25 pm | May 15, 2023
Medicare annual spending on lecanemab's medication costs alone would place it among the most expensive Part B medications.
By Jeff Lagasse | 12:15 pm | May 05, 2023
Lawmakers expressed concern that the DEA's plan to roll back flexibilities could make OUD medication more difficult to obtain.
By Jeff Lagasse | 10:25 am | May 04, 2023
Still, Eli Lilly is touting the results, which demonstrate effectiveness at slowing the progression of the disease.
By Susan Morse | 11:29 am | May 03, 2023
Both cite as a reason the implications of a court overriding drug decisions by the FDA. 
HIMSS23
By HIMSS TV | 12:00 pm | May 02, 2023
<p>Targeted medication alerts use genetic and EHR information to warn of treatment issues when it really matters, says Anna Dover, director of product management at First Databank.</p>
By Susan Morse | 10:55 am | April 24, 2023
Big Pharma spends millions attempting to deflect blame, limit competition, and undermine patients' bargaining power, AHIP says.
By Susan Morse | 11:20 am | March 29, 2023
The FDA has approved the first nonprescription OTC naloxone nasal spray, Narcan.
By Jeff Lagasse | 03:34 pm | March 28, 2023
The AG has alleged that Express Scripts has used its market dominance solely for its financial gain.